Novo Holdings creates Hemab
Danish Novo Holdings has founded Hemab ApS that is focussed on fighting orphan bleeding disorders by bi-specific antibodies.
ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 2066 entries already.
Entries by Thomas Gabrielczyk
Biotech companies launch Biotech Austria
Austria has needed a biotech association for a long time. In just two months, entrepreneurs have launched Biotech Austria.
How microplastic particles get into the body
Weathered microplastic particles may pose a greater risk than pristine ones, suggests a study of German researchers on mouse cells.
Centogene and Anylam launch clinical programme
Diagnostics developer Centogene NV and Alnylam Pharmaceuticals launched a clinical programme aimed at improving ATTRv diagnosis.
Avantium NV bags money for demo plant
Green chemistry company Avantium NV has secured a €7.5m funding from the National Programme Groningen to support the construction of a 5 kilotonnes FDCA plant.
22nd German Biotech Guide now also digital!
The digital version of the 22nd Guide to German Biotech Companies is now available via the free BIOCOM App! Available for smartphone and tablet users via Apple App Store and Android Store.
How stress brings cancer to life again
Stress hormones such as cortisol or norephidrine can reawaken dormant tumour cells, a research team led by AstraZeneca has found out.
UK approves Biontech/Pfizer Covid-19 vaccine (copy 1)
Biontech and Pfizer have received emergency approval for their COVID-19 vaccine in the UK. Mass immunization could start next week, the first in Western countries.
UK approves Biontech/Pfizer Covid-19 vaccine
Biontech and Pfizer have received emergency approval for their COVID-19 vaccine in the UK. Mass immunization could start next week, the first in Western countries.
Swiss Noema Pharma raises CHF54m in Series A financing
Noema Pharma AG kicks off with CHF54m and licenced drug candidates from Roche AG.